The integration of advanced experience, expertise, and technology makes the Ichilov clinic an attractive option for patients from around the world. The medical center regularly incorporates the latest advancements in lymphoma therapy into clinical protocols, including the newest drugs and technologies. Treatment of the non-leukemic variant of B-cell lymphoma in Israel is based on a personalized plan that takes into account the individual characteristics and specifics of the disease's progression in each patient.
At the clinic, a comprehensive approach to treatment and close collaboration among specialists from various fields are practiced. The Ichilov medical center is equipped with the most modern diagnostic equipment, allowing for high precision in determining the nature and stage of the disease. The clinic collaborates with leading oncology centers worldwide, and doctors regularly participate in professional internships, research, and training. Patients receive medical assistance and psychological support necessary for successful treatment and recovery.
About the Disease
The non-leukemic variant of B-cell lymphoma belongs to the group of non-Hodgkin lymphomas that develop from B-lymphocytes – a type of white blood cell responsible for the immune response. These diseases are a form of malignant tumours of the lymphatic system.
Non-Hodgkin lymphomas are classified according to several criteria, including the growth rate of the neoplasm (indolent or aggressive), morphological features, immunophenotyping, and genetic changes. Depending on these factors, B-cell lymphomas are divided into numerous subtypes.
The specific cause of most non-Hodgkin lymphomas is unknown. It is believed that their development is due to a combination of genetic mutations and external factors such as infections, viruses, chemical carcinogens, radiation exposure, and immune disorders.
Signs of B-cell lymphoma cover a wide range, from asymptomatic progression to severe clinical manifestations, which may include:
- painless enlargement of one or more lymph nodes;
- abdominal pain potentially associated with spleen or abdominal lymph node enlargement;
- sensation of fullness after eating;
- skin rashes or itching;
- night sweats;
- fever not associated with infections;
- unexplained weight loss;
- fatigue, malaise.
Treatment Methods for the Disease
Treatment of the non-leukemic variant of B-cell lymphoma depends on the stage of the process, the overall condition of the patient, age, and other factors. Most often, combined therapy includes chemotherapy, radiotherapy, immunotherapy, targeted therapy, and stem cell transplantation. The appropriateness of each method is discussed by a team of doctors who select options based on international protocols, taking into account the individual characteristics of each case.
Chemotherapy
Various antitumor drugs for destroying cancer cells can be used alone (monotherapy) or in combinations (polychemotherapy).
Chemotherapy is considered the primary method for treating the non-leukemic variant of B-cell lymphoma due to the high ability of chemotherapeutic agents to destroy cancer cells, especially rapidly dividing ones. Lymphomas often affect multiple groups of lymph nodes and other organs, making local treatment methods, such as surgical removal or radiotherapy, insufficiently effective. Chemotherapy, spreading through the bloodstream, can “reach” cancer cells throughout the body.
Immunotherapy, Monoclonal Antibody Therapy
These are modern approaches to treating tumours that utilize natural mechanisms of the immune system to combat cancer cells. Their advantages over traditional chemotherapy include limited impact on healthy cells and significantly fewer side effects.
- Immunotherapy activates or enhances the patient's immune system as a whole, allowing it to more effectively recognize and attack cancer cells.
- Monoclonal antibody therapy uses specialized proteins developed in laboratories that specifically target certain molecules (antigens) on the surface of cancer cells, leading to their destruction.
Both methods make treatment targeted and effective, reduce the chances of relapse, improve prognosis, and overall outcomes.
Targeted Therapy
Targeted therapy for treating non-leukemic variants of B-cell lymphomas involves directed action on specific molecular targets inherent to cancer cells. Targeted drugs are developed to attack specific proteins or genetic mechanisms that distinguish cancer cells from healthy ones. This minimizes damage to normal cells and reduces side effects.
Since these drugs target critical processes essential for tumour functioning, they provide a more pronounced therapeutic effect, improved predictability of response, fewer unforeseen reactions, and long-term effectiveness.
Radiotherapy
Radiotherapy is most often applied:
- in combination with chemotherapy;
- as part of consolidation (refining) treatment after chemotherapy, especially in the case of primary lymphomas localized in a specific area or organ;
- to consolidate results by destroying remaining cancer cells that may not be visible even on the most modern scanners.
The Ichilov clinic operates the latest models of linear accelerators, TrueBeam and Lunac, allowing for precise irradiation of tumours localized in one area or organ. Intensity-modulated radiotherapy and image-guided radiation therapy (IGRT) minimize damage to healthy tissues, reducing side effects. These technologies help doctors more accurately target zonal tumours and instantly adapt the process to changes in the size and shape of the tumour during treatment.
Steroid Therapy
Steroid medications, including corticosteroids, play an important role in treating the non-leukemic variant of B-cell lymphomas. They have:
- anti-inflammatory effects, effectively reducing inflammation and swelling in the area of the tumour;
- antitumor effects, inducing apoptosis (programmed cell death) in cancer cells sensitive to these drugs;
- immune system suppression effects, useful for reducing autoimmune reactions or managing situations where the immune system reacts too aggressively;
- chemotherapy enhancement effects.
Stem Cell Transplantation
Stem cell transplantation in the treatment of the non-leukemic variant of B-cell lymphomas is used as a restorative therapy after intensive treatment, most often high-dose chemotherapy or radiation therapy. These therapeutic measures aim to completely destroy cancer cells but can harm healthy bone marrow cells responsible for blood production. In such cases, transplantation of autologous or donor cells is used, which:
- restores bone marrow functions, stimulating the production of healthy hematopoietic cells;
- allows doctors to use higher doses of chemotherapeutic agents due to the restoration of bone marrow;
- creates a “new” immunity in the case of allogeneic transplantation, where stem cells are taken from a donor.
Surgical Treatment
Surgical treatment is most effective in the early stages of the disease when the tumour is accessible for removal and has not spread to other areas of the body. Surgery is also used to achieve local control to prevent further spread or reduce the size of the formation.
Depending on the location and size of the tumour, various surgical techniques may be used:
- traditional open surgery;
- minimally invasive surgeries using endoscopic methods with small incisions and special instruments. The latest technological advancements in surgery, such as robot-assisted surgery, allow for more precise operations with less damage to surrounding tissues and a shorter recovery period.
- Stem cell treatment
- Surgery in Israel
- Radiotherapy
- Chemotherapy
Diagnostic Methods for the Disease
The diagnosis of the non-leukemic variant of B-cell lymphoma is a comprehensive process and includes a range of studies and procedures. At the Ichilov clinic, an accurate diagnosis can be made in no more than three days.
First Day
Conversation with the patient to identify symptoms, collection of complaints, compilation of medical history. Mandatory physical examination with palpation of lymph nodes.
Second Day
- Laboratory tests: complete blood count (CBC), biochemical blood analysis, tests for tumor markers or viral infections that may contribute to the development of lymphoma.
- Instrumental studies: CT, MRI, PET.
- Biopsy of the enlarged lymph node with examination of the tissue sample to determine the type of lymphoma.
- Additional investigative methods: immunohistochemistry, cytogenetic studies, molecular genetic analysis.
- Myelogram and bone marrow biopsy.
Third Day
To analyze the results of the studies, the Ichilov clinic involves a multidisciplinary team of doctors: hematologists, oncologists, surgeons, radiologists, and histopathologists. In some cases, other specialists may also be involved: radiation therapists, transplantologists, clinical pharmacologists, geneticists, and doctors from other specialties. A comprehensive approach allows for each clinical case to be considered from all angles, taking into account the nuances and specifics of the disease's progression in each patient to develop the most effective treatment plan.
- Biopsy
- Bone marrow biopsy
- Computed tomography
- Magnetic Resonance Imaging (MRI)
- Diagnosis — PET CT
- Blood biochemistry
How Much Does Treatment Cost
The cost of the treatment program can vary significantly. It depends on the stage of the disease, accompanying pathologies, overall condition, age, and individual characteristics of the disease's progression. The price is composed of the sum of diagnostic and therapeutic procedures, their quantity and complexity. The calculation of combined therapy takes into account chemotherapy drugs, the number of radiotherapy sessions, the complexity and time required to prepare individual components of immunotherapy and targeted therapy, and the need for stem cell transplantation.
You can call the number listed on the website right now and inquire about the preliminary estimate of the treatment program. A medical consultant will explain how to organize the trip, what documents are needed, how to find ratings and reviews about the clinic and specific doctors. Write your questions in the special feedback form or ask them through the online chat.
Advantages of Treating the Non-Leukemic Variant of B-Cell Lymphoma in Israel
- Innovative treatment methods and an individual approach to patients
- Interdisciplinary consultations, advanced diagnostic and therapeutic procedures
- Professionalism and experience of medical staff
- Patient support throughout the entire treatment course
- Experience in working with foreign patients, premium quality of medical services
Do not delay treatment – order a remote consultation with a leading physician who has practical experience in treating the non-leukemic variant of B-cell lymphoma right now. The doctor will consult via video link through Zoom or Skype, explaining what treatment options exist and what steps to take regarding your specific case.